Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious ...

The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

Adalimumab had superior efficacy and safety outcomes compared with secukinumab and bimekizumab for the treatment of hidradenitis suppurativa.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.